(NP (NP Lymphocyte/NN glucocorticoid/NN receptor/NN binding/NN) (PP-TMP-COOD (PP during/IN (NP depression/NN)) and/CC (PP after/IN (NP clinical/JJ recovery/NN))) ./.)
(S (NP-SBJ-58 Lymphocyte/NN glucocorticoid/NN receptor/NN binding/NN parameters/NNS) (VP were/VBD (VP-COOD (VP studied/VBN (NP *-58/-NONE-) (PP-106 in/IN (NP 15/CD (ADJP severely/RB depressed/JJ) patients/NNS)) (PP-TMP-COOD (PP during/IN (NP depression/NN)) and/CC (PP after/IN (NP clinical/JJ recovery/NN)))) ,/, and/CC (VP (PP=106 in/IN (NP 15/CD healthy/JJ controls/NNS))))) ./.)
(S (NP-SBJ There/EX) (VP was/VBD (NP-PRD (NP no/DT difference/NN) (PP in/IN (NP glucocorticoid/NN receptor/NN (NP-COOD (NP number/NN) or/CC (NP affinity/NN)))) (PP between/IN (NP-COOD (NP depressed/JJ patients/NNS) and/CC (NP (ADJP-COOD (ADJP recovered/JJ) or/CC (ADJP control/NN)) subjects/NNS))))) ./.)
(S (NP-SBJ Afternoon/NN (NP-COOD (NP ACTH/NN) and/CC (NP cortisol/NN)) concentrations/NNS) (VP did/VBD not/RB (VP differ/VB (ADVP significantly/RB) (PP between/IN (NP the/DT three/CD groups/NNS)))) ./.)
(S (NP-SBJ-59 No/DT relationship/NN) (VP could/MD (VP be/VB (VP established/VBN (NP *-59/-NONE-) (PP between/IN (NP-COOD (NP glucocorticoid/NN receptor/NN binding/NN) and/CC (NP antidepressant/JJ medication/NN)))))) ./.)
(S (NP-SBJ These/DT data/NNS) (VP support/VBP (NP-COOD (NP (NP the/DT view/NN) (PP of/IN (NP (NP an/DT (ADJP impaired/JJ ligand-induced/JJ) plasticity/NN) (PP of/IN (NP glucocorticoid/NN receptor/NN regulation/NN))))) (CONJP rather/RB than/IN) (NP (NP the/DT hypothesis/NN) (PP of/IN (NP (NP decreased/VBN glucocorticoid/NN receptor/NN numbers/NNS) (PP-TMP during/IN (NP depression/NN))))))) ./.)
